There are currently three investors in CapeRay: the Industrial Development Corporation, the University of Cape Town and Kit Vaughan, who between them own over 90% of the shares in the company.
CapeRay Medical (Pty) Ltd has developed novel and leading-edge breast imaging technology with its dual-modality Aceso system. The benefits to patients and doctors include: earlier diagnosis of breast cancer; greater potential for saving lives; reduced breast compression; greater patient throughput; lower radiation dose; and reduced capital outlay. Management believes CapeRay’s technology could allow an investor to exploit the strong and growing market for breast imaging.